Influence of muscle mass in the assessment of lower limb strength in COPD: validation of the prediction equation.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 28866643.
- Also identified by DOI 10.1136/thoraxjnl-2016-209870.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Absence of established reference values limits application of quadriceps maximal voluntary contraction (QMVC) measurement. The impact of muscle mass inclusion in predictions is unclear. Prediction equations encompassing gender, age and size with (FFM+) and without (FFM-), derived in healthy adults (n=175), are presented and compared in two COPD cohorts recruited from primary care (COPD-PC, n=112) and a complex care COPD clinic (COPD-CC, n=189). Explained variance was comparable between the prediction models (R2: FFM+: 0.59, FFM-: 0.60) as were per cent predictions in COPD-PC (88.8%, 88.3%). However, fat-free mass inclusion reduced the prevalence of weakness in COPD, particularly in COPD-CC where 11.9% fewer were deemed weak.
Medical subject headings
- Lower Extremity
- Muscle Strength
- Pulmonary Disease, Chronic Obstructive
- Quadriceps Muscle